Inequalities in Financial Distress, Symptoms, and Quality of Life Among Patients with Advanced Cancer in France and the U.S.
Identifieur interne : 000533 ( Main/Exploration ); précédent : 000532; suivant : 000534Inequalities in Financial Distress, Symptoms, and Quality of Life Among Patients with Advanced Cancer in France and the U.S.
Auteurs : Cécile Barbaret [France] ; Marvin O. Delgado-Guay [États-Unis] ; Stéphane Sanchez [France] ; Christelle Brosse [France] ; Murielle Ruer [France] ; Wadih Rhondali [France] ; Léa Monsarrat [France] ; Patrick Michaud [France] ; Anne Marie Schott [France] ; Eduardo Bruera [États-Unis] ; Marilène Filbet [France]Source :
- The oncologist [ 1549-490X ] ; 2019.
Descripteurs français
- KwdFr :
- Adulte d'âge moyen (MeSH), Autorapport (statistiques et données numériques), Comparaison interculturelle (MeSH), Coûts indirects de la maladie (MeSH), Disparités de l'état de santé (MeSH), Facteurs socioéconomiques (MeSH), Femelle (MeSH), France (MeSH), Humains (MeSH), Mâle (MeSH), Qualité de vie (MeSH), Stadification tumorale (MeSH), Sujet âgé (MeSH), Tumeurs (anatomopathologie), Tumeurs (complications), Tumeurs (psychologie), Tumeurs (économie), États-Unis (MeSH), Études de cohortes (MeSH), Études transversales (MeSH).
- MESH :
- anatomopathologie : Tumeurs.
- psychologie : Tumeurs.
- statistiques et données numériques : Autorapport.
- économie : Tumeurs.
- Adulte d'âge moyen, Comparaison interculturelle, Coûts indirects de la maladie, Disparités de l'état de santé, Facteurs socioéconomiques, Femelle, France, Humains, Mâle, Qualité de vie, Stadification tumorale, Sujet âgé, Tumeurs, États-Unis, Études de cohortes, Études transversales.
- Wicri :
- geographic : France, États-Unis.
English descriptors
- KwdEn :
- Aged (MeSH), Cohort Studies (MeSH), Cost of Illness (MeSH), Cross-Cultural Comparison (MeSH), Cross-Sectional Studies (MeSH), Female (MeSH), France (MeSH), Health Status Disparities (MeSH), Humans (MeSH), Male (MeSH), Middle Aged (MeSH), Neoplasm Staging (MeSH), Neoplasms (complications), Neoplasms (economics), Neoplasms (pathology), Neoplasms (psychology), Quality of Life (MeSH), Self Report (statistics & numerical data), Socioeconomic Factors (MeSH), United States (MeSH).
- MESH :
- geographic : France, United States.
- complications : Neoplasms.
- economics : Neoplasms.
- pathology : Neoplasms.
- psychology : Neoplasms.
- statistics & numerical data : Self Report.
- Aged, Cohort Studies, Cost of Illness, Cross-Cultural Comparison, Cross-Sectional Studies, Female, Health Status Disparities, Humans, Male, Middle Aged, Neoplasm Staging, Quality of Life, Socioeconomic Factors.
Abstract
BACKGROUND
Financial distress (FD) is common among patients with advanced cancer. Our purpose was to compare the frequency and intensity of FD and its associations with symptom distress and quality of life (QOL) in these patients in France and the U.S.
MATERIALS AND METHODS
In this secondary analysis of two cross-sectional studies, we assessed data on 292 patients who received cancer care at a public hospital or a comprehensive cancer center in France (143 patients) or the U.S. (149 patients). Outpatients and hospitalized patients over 18 years of age with advanced lung or breast or colorectal or prostate cancer were included. Diagnosed cognitive disorder was considered a noninclusion criterion. Advanced cancer included relapse or metastasis or locally advanced cancer or at least a second-line chemotherapy regimen. Patients self-rated FD and assessed symptoms, psychosocial distress, and QOL on validated questionnaires.
RESULTS
The average patient age was 59 years, and 144 (49%) were female. FD and high intensity were reported more frequently in U.S. patients than in French (respectively 129 [88%] vs. 74 [52%],
CONCLUSION
Regardless of health care system, FD is frequent in patients with advanced cancer. U.S. patients were more likely to have FD than French patients but reported better QOL. Further research should focus on factors contributing to FD and opportunities for remediation.
IMPLICATIONS FOR PRACTICE
Suffering is experienced in any component of the lives of patients with a life-threatening illness. Financial distress (FD) is one of the least explored cancer-related symptoms, and there are limited studies describing its impact on this frail population. This study highlights the high frequency and severity of FD in patients with advanced cancer in the U.S. and France as well as its impact on their physical and emotional symptoms and their quality of life in these different health care systems. It is necessary for all health care providers to explore and evaluate the presence of FD in patients living with life-threatening illnesses.
DOI: 10.1634/theoncologist.2018-0353
PubMed: 30877191
PubMed Central: PMC6693692
Affiliations:
- France, États-Unis
- Auvergne-Rhône-Alpes, Champagne-Ardenne, Grand Est, Rhône-Alpes, Texas
- Lyon, Saint-Étienne, Troyes
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Inequalities in Financial Distress, Symptoms, and Quality of Life Among Patients with Advanced Cancer in France and the U.S.</title><author><name sortKey="Barbaret, Cecile" sort="Barbaret, Cecile" uniqKey="Barbaret C" first="Cécile" last="Barbaret">Cécile Barbaret</name><affiliation wicri:level="1"><nlm:affiliation>Department of Supportive and Palliative Care, Centre Hospitalo-Universitaire de Grenoble, La Tronche, France cbarbaret@chu-grenoble.fr.</nlm:affiliation><country wicri:rule="url">France</country><wicri:regionArea>Department of Supportive and Palliative Care, Centre Hospitalo-Universitaire de Grenoble, La Tronche</wicri:regionArea><wicri:noRegion>La Tronche</wicri:noRegion><wicri:noRegion>La Tronche</wicri:noRegion></affiliation></author><author><name sortKey="Delgado Guay, Marvin O" sort="Delgado Guay, Marvin O" uniqKey="Delgado Guay M" first="Marvin O" last="Delgado-Guay">Marvin O. Delgado-Guay</name><affiliation wicri:level="2"><nlm:affiliation>Department of Palliative, Rehabilitation, and Integrative Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, U.S.A.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Palliative, Rehabilitation, and Integrative Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas</wicri:regionArea><placeName><region type="state">Texas</region></placeName></affiliation></author><author><name sortKey="Sanchez, Stephane" sort="Sanchez, Stephane" uniqKey="Sanchez S" first="Stéphane" last="Sanchez">Stéphane Sanchez</name><affiliation wicri:level="3"><nlm:affiliation>Department of Medical Information, Evaluation and Performance, Hôpitaux Champagne Sud, Troyes, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Department of Medical Information, Evaluation and Performance, Hôpitaux Champagne Sud, Troyes</wicri:regionArea><placeName><region type="region">Grand Est</region><region type="old region">Champagne-Ardenne</region><settlement type="city">Troyes</settlement></placeName></affiliation></author><author><name sortKey="Brosse, Christelle" sort="Brosse, Christelle" uniqKey="Brosse C" first="Christelle" last="Brosse">Christelle Brosse</name><affiliation wicri:level="3"><nlm:affiliation>Department of Palliative Care, Institut de Cancérologie de la Loire, Saint-Etienne, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Department of Palliative Care, Institut de Cancérologie de la Loire, Saint-Etienne</wicri:regionArea><placeName><region type="region">Auvergne-Rhône-Alpes</region><region type="old region">Rhône-Alpes</region><settlement type="city">Saint-Étienne</settlement></placeName></affiliation></author><author><name sortKey="Ruer, Murielle" sort="Ruer, Murielle" uniqKey="Ruer M" first="Murielle" last="Ruer">Murielle Ruer</name><affiliation wicri:level="3"><nlm:affiliation>Department of Supportive and Palliative Care, Centre Hospitalier Lyon-Sud, Lyon, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Department of Supportive and Palliative Care, Centre Hospitalier Lyon-Sud, Lyon</wicri:regionArea><placeName><region type="region">Auvergne-Rhône-Alpes</region><region type="old region">Rhône-Alpes</region><settlement type="city">Lyon</settlement></placeName></affiliation></author><author><name sortKey="Rhondali, Wadih" sort="Rhondali, Wadih" uniqKey="Rhondali W" first="Wadih" last="Rhondali">Wadih Rhondali</name><affiliation wicri:level="3"><nlm:affiliation>Department of Supportive and Palliative Care, Centre Hospitalier Lyon-Sud, Lyon, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Department of Supportive and Palliative Care, Centre Hospitalier Lyon-Sud, Lyon</wicri:regionArea><placeName><region type="region">Auvergne-Rhône-Alpes</region><region type="old region">Rhône-Alpes</region><settlement type="city">Lyon</settlement></placeName></affiliation></author><author><name sortKey="Monsarrat, Lea" sort="Monsarrat, Lea" uniqKey="Monsarrat L" first="Léa" last="Monsarrat">Léa Monsarrat</name><affiliation wicri:level="3"><nlm:affiliation>Department of Supportive and Palliative Care, Centre Hospitalier Lyon-Sud, Lyon, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Department of Supportive and Palliative Care, Centre Hospitalier Lyon-Sud, Lyon</wicri:regionArea><placeName><region type="region">Auvergne-Rhône-Alpes</region><region type="old region">Rhône-Alpes</region><settlement type="city">Lyon</settlement></placeName></affiliation></author><author><name sortKey="Michaud, Patrick" sort="Michaud, Patrick" uniqKey="Michaud P" first="Patrick" last="Michaud">Patrick Michaud</name><affiliation wicri:level="3"><nlm:affiliation>Department of Palliative Care, Institut de Cancérologie de la Loire, Saint-Etienne, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Department of Palliative Care, Institut de Cancérologie de la Loire, Saint-Etienne</wicri:regionArea><placeName><region type="region">Auvergne-Rhône-Alpes</region><region type="old region">Rhône-Alpes</region><settlement type="city">Saint-Étienne</settlement></placeName></affiliation></author><author><name sortKey="Schott, Anne Marie" sort="Schott, Anne Marie" uniqKey="Schott A" first="Anne Marie" last="Schott">Anne Marie Schott</name><affiliation wicri:level="3"><nlm:affiliation>Pôle IMER, Hospices Civils de Lyon, Lyon, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Pôle IMER, Hospices Civils de Lyon, Lyon</wicri:regionArea><placeName><region type="region">Auvergne-Rhône-Alpes</region><region type="old region">Rhône-Alpes</region><settlement type="city">Lyon</settlement></placeName></affiliation></author><author><name sortKey="Bruera, Eduardo" sort="Bruera, Eduardo" uniqKey="Bruera E" first="Eduardo" last="Bruera">Eduardo Bruera</name><affiliation wicri:level="2"><nlm:affiliation>Department of Palliative, Rehabilitation, and Integrative Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, U.S.A.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Palliative, Rehabilitation, and Integrative Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas</wicri:regionArea><placeName><region type="state">Texas</region></placeName></affiliation></author><author><name sortKey="Filbet, Marilene" sort="Filbet, Marilene" uniqKey="Filbet M" first="Marilène" last="Filbet">Marilène Filbet</name><affiliation wicri:level="3"><nlm:affiliation>Department of Supportive and Palliative Care, Centre Hospitalier Lyon-Sud, Lyon, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Department of Supportive and Palliative Care, Centre Hospitalier Lyon-Sud, Lyon</wicri:regionArea><placeName><region type="region">Auvergne-Rhône-Alpes</region><region type="old region">Rhône-Alpes</region><settlement type="city">Lyon</settlement></placeName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2019">2019</date><idno type="RBID">pubmed:30877191</idno><idno type="pmid">30877191</idno><idno type="doi">10.1634/theoncologist.2018-0353</idno><idno type="pmc">PMC6693692</idno><idno type="wicri:Area/Main/Corpus">000552</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000552</idno><idno type="wicri:Area/Main/Curation">000552</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000552</idno><idno type="wicri:Area/Main/Exploration">000552</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Inequalities in Financial Distress, Symptoms, and Quality of Life Among Patients with Advanced Cancer in France and the U.S.</title><author><name sortKey="Barbaret, Cecile" sort="Barbaret, Cecile" uniqKey="Barbaret C" first="Cécile" last="Barbaret">Cécile Barbaret</name><affiliation wicri:level="1"><nlm:affiliation>Department of Supportive and Palliative Care, Centre Hospitalo-Universitaire de Grenoble, La Tronche, France cbarbaret@chu-grenoble.fr.</nlm:affiliation><country wicri:rule="url">France</country><wicri:regionArea>Department of Supportive and Palliative Care, Centre Hospitalo-Universitaire de Grenoble, La Tronche</wicri:regionArea><wicri:noRegion>La Tronche</wicri:noRegion><wicri:noRegion>La Tronche</wicri:noRegion></affiliation></author><author><name sortKey="Delgado Guay, Marvin O" sort="Delgado Guay, Marvin O" uniqKey="Delgado Guay M" first="Marvin O" last="Delgado-Guay">Marvin O. Delgado-Guay</name><affiliation wicri:level="2"><nlm:affiliation>Department of Palliative, Rehabilitation, and Integrative Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, U.S.A.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Palliative, Rehabilitation, and Integrative Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas</wicri:regionArea><placeName><region type="state">Texas</region></placeName></affiliation></author><author><name sortKey="Sanchez, Stephane" sort="Sanchez, Stephane" uniqKey="Sanchez S" first="Stéphane" last="Sanchez">Stéphane Sanchez</name><affiliation wicri:level="3"><nlm:affiliation>Department of Medical Information, Evaluation and Performance, Hôpitaux Champagne Sud, Troyes, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Department of Medical Information, Evaluation and Performance, Hôpitaux Champagne Sud, Troyes</wicri:regionArea><placeName><region type="region">Grand Est</region><region type="old region">Champagne-Ardenne</region><settlement type="city">Troyes</settlement></placeName></affiliation></author><author><name sortKey="Brosse, Christelle" sort="Brosse, Christelle" uniqKey="Brosse C" first="Christelle" last="Brosse">Christelle Brosse</name><affiliation wicri:level="3"><nlm:affiliation>Department of Palliative Care, Institut de Cancérologie de la Loire, Saint-Etienne, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Department of Palliative Care, Institut de Cancérologie de la Loire, Saint-Etienne</wicri:regionArea><placeName><region type="region">Auvergne-Rhône-Alpes</region><region type="old region">Rhône-Alpes</region><settlement type="city">Saint-Étienne</settlement></placeName></affiliation></author><author><name sortKey="Ruer, Murielle" sort="Ruer, Murielle" uniqKey="Ruer M" first="Murielle" last="Ruer">Murielle Ruer</name><affiliation wicri:level="3"><nlm:affiliation>Department of Supportive and Palliative Care, Centre Hospitalier Lyon-Sud, Lyon, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Department of Supportive and Palliative Care, Centre Hospitalier Lyon-Sud, Lyon</wicri:regionArea><placeName><region type="region">Auvergne-Rhône-Alpes</region><region type="old region">Rhône-Alpes</region><settlement type="city">Lyon</settlement></placeName></affiliation></author><author><name sortKey="Rhondali, Wadih" sort="Rhondali, Wadih" uniqKey="Rhondali W" first="Wadih" last="Rhondali">Wadih Rhondali</name><affiliation wicri:level="3"><nlm:affiliation>Department of Supportive and Palliative Care, Centre Hospitalier Lyon-Sud, Lyon, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Department of Supportive and Palliative Care, Centre Hospitalier Lyon-Sud, Lyon</wicri:regionArea><placeName><region type="region">Auvergne-Rhône-Alpes</region><region type="old region">Rhône-Alpes</region><settlement type="city">Lyon</settlement></placeName></affiliation></author><author><name sortKey="Monsarrat, Lea" sort="Monsarrat, Lea" uniqKey="Monsarrat L" first="Léa" last="Monsarrat">Léa Monsarrat</name><affiliation wicri:level="3"><nlm:affiliation>Department of Supportive and Palliative Care, Centre Hospitalier Lyon-Sud, Lyon, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Department of Supportive and Palliative Care, Centre Hospitalier Lyon-Sud, Lyon</wicri:regionArea><placeName><region type="region">Auvergne-Rhône-Alpes</region><region type="old region">Rhône-Alpes</region><settlement type="city">Lyon</settlement></placeName></affiliation></author><author><name sortKey="Michaud, Patrick" sort="Michaud, Patrick" uniqKey="Michaud P" first="Patrick" last="Michaud">Patrick Michaud</name><affiliation wicri:level="3"><nlm:affiliation>Department of Palliative Care, Institut de Cancérologie de la Loire, Saint-Etienne, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Department of Palliative Care, Institut de Cancérologie de la Loire, Saint-Etienne</wicri:regionArea><placeName><region type="region">Auvergne-Rhône-Alpes</region><region type="old region">Rhône-Alpes</region><settlement type="city">Saint-Étienne</settlement></placeName></affiliation></author><author><name sortKey="Schott, Anne Marie" sort="Schott, Anne Marie" uniqKey="Schott A" first="Anne Marie" last="Schott">Anne Marie Schott</name><affiliation wicri:level="3"><nlm:affiliation>Pôle IMER, Hospices Civils de Lyon, Lyon, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Pôle IMER, Hospices Civils de Lyon, Lyon</wicri:regionArea><placeName><region type="region">Auvergne-Rhône-Alpes</region><region type="old region">Rhône-Alpes</region><settlement type="city">Lyon</settlement></placeName></affiliation></author><author><name sortKey="Bruera, Eduardo" sort="Bruera, Eduardo" uniqKey="Bruera E" first="Eduardo" last="Bruera">Eduardo Bruera</name><affiliation wicri:level="2"><nlm:affiliation>Department of Palliative, Rehabilitation, and Integrative Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, U.S.A.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Palliative, Rehabilitation, and Integrative Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas</wicri:regionArea><placeName><region type="state">Texas</region></placeName></affiliation></author><author><name sortKey="Filbet, Marilene" sort="Filbet, Marilene" uniqKey="Filbet M" first="Marilène" last="Filbet">Marilène Filbet</name><affiliation wicri:level="3"><nlm:affiliation>Department of Supportive and Palliative Care, Centre Hospitalier Lyon-Sud, Lyon, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Department of Supportive and Palliative Care, Centre Hospitalier Lyon-Sud, Lyon</wicri:regionArea><placeName><region type="region">Auvergne-Rhône-Alpes</region><region type="old region">Rhône-Alpes</region><settlement type="city">Lyon</settlement></placeName></affiliation></author></analytic><series><title level="j">The oncologist</title><idno type="eISSN">1549-490X</idno><imprint><date when="2019" type="published">2019</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aged (MeSH)</term><term>Cohort Studies (MeSH)</term><term>Cost of Illness (MeSH)</term><term>Cross-Cultural Comparison (MeSH)</term><term>Cross-Sectional Studies (MeSH)</term><term>Female (MeSH)</term><term>France (MeSH)</term><term>Health Status Disparities (MeSH)</term><term>Humans (MeSH)</term><term>Male (MeSH)</term><term>Middle Aged (MeSH)</term><term>Neoplasm Staging (MeSH)</term><term>Neoplasms (complications)</term><term>Neoplasms (economics)</term><term>Neoplasms (pathology)</term><term>Neoplasms (psychology)</term><term>Quality of Life (MeSH)</term><term>Self Report (statistics & numerical data)</term><term>Socioeconomic Factors (MeSH)</term><term>United States (MeSH)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adulte d'âge moyen (MeSH)</term><term>Autorapport (statistiques et données numériques)</term><term>Comparaison interculturelle (MeSH)</term><term>Coûts indirects de la maladie (MeSH)</term><term>Disparités de l'état de santé (MeSH)</term><term>Facteurs socioéconomiques (MeSH)</term><term>Femelle (MeSH)</term><term>France (MeSH)</term><term>Humains (MeSH)</term><term>Mâle (MeSH)</term><term>Qualité de vie (MeSH)</term><term>Stadification tumorale (MeSH)</term><term>Sujet âgé (MeSH)</term><term>Tumeurs (anatomopathologie)</term><term>Tumeurs (complications)</term><term>Tumeurs (psychologie)</term><term>Tumeurs (économie)</term><term>États-Unis (MeSH)</term><term>Études de cohortes (MeSH)</term><term>Études transversales (MeSH)</term></keywords><keywords scheme="MESH" type="geographic" xml:lang="en"><term>France</term><term>United States</term></keywords><keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr"><term>Tumeurs</term></keywords><keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Neoplasms</term></keywords><keywords scheme="MESH" qualifier="economics" xml:lang="en"><term>Neoplasms</term></keywords><keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Neoplasms</term></keywords><keywords scheme="MESH" qualifier="psychologie" xml:lang="fr"><term>Tumeurs</term></keywords><keywords scheme="MESH" qualifier="psychology" xml:lang="en"><term>Neoplasms</term></keywords><keywords scheme="MESH" qualifier="statistics & numerical data" xml:lang="en"><term>Self Report</term></keywords><keywords scheme="MESH" qualifier="statistiques et données numériques" xml:lang="fr"><term>Autorapport</term></keywords><keywords scheme="MESH" qualifier="économie" xml:lang="fr"><term>Tumeurs</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Aged</term><term>Cohort Studies</term><term>Cost of Illness</term><term>Cross-Cultural Comparison</term><term>Cross-Sectional Studies</term><term>Female</term><term>Health Status Disparities</term><term>Humans</term><term>Male</term><term>Middle Aged</term><term>Neoplasm Staging</term><term>Quality of Life</term><term>Socioeconomic Factors</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adulte d'âge moyen</term><term>Comparaison interculturelle</term><term>Coûts indirects de la maladie</term><term>Disparités de l'état de santé</term><term>Facteurs socioéconomiques</term><term>Femelle</term><term>France</term><term>Humains</term><term>Mâle</term><term>Qualité de vie</term><term>Stadification tumorale</term><term>Sujet âgé</term><term>Tumeurs</term><term>États-Unis</term><term>Études de cohortes</term><term>Études transversales</term></keywords><keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>France</term><term>États-Unis</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><p><b>BACKGROUND</b></p><p>Financial distress (FD) is common among patients with advanced cancer. Our purpose was to compare the frequency and intensity of FD and its associations with symptom distress and quality of life (QOL) in these patients in France and the U.S.</p></div><div type="abstract" xml:lang="en"><p><b>MATERIALS AND METHODS</b></p><p>In this secondary analysis of two cross-sectional studies, we assessed data on 292 patients who received cancer care at a public hospital or a comprehensive cancer center in France (143 patients) or the U.S. (149 patients). Outpatients and hospitalized patients over 18 years of age with advanced lung or breast or colorectal or prostate cancer were included. Diagnosed cognitive disorder was considered a noninclusion criterion. Advanced cancer included relapse or metastasis or locally advanced cancer or at least a second-line chemotherapy regimen. Patients self-rated FD and assessed symptoms, psychosocial distress, and QOL on validated questionnaires.</p></div><div type="abstract" xml:lang="en"><p><b>RESULTS</b></p><p>The average patient age was 59 years, and 144 (49%) were female. FD and high intensity were reported more frequently in U.S. patients than in French (respectively 129 [88%] vs. 74 [52%], </p></div><div type="abstract" xml:lang="en"><p><b>CONCLUSION</b></p><p>Regardless of health care system, FD is frequent in patients with advanced cancer. U.S. patients were more likely to have FD than French patients but reported better QOL. Further research should focus on factors contributing to FD and opportunities for remediation.</p></div><div type="abstract" xml:lang="en"><p><b>IMPLICATIONS FOR PRACTICE</b></p><p>Suffering is experienced in any component of the lives of patients with a life-threatening illness. Financial distress (FD) is one of the least explored cancer-related symptoms, and there are limited studies describing its impact on this frail population. This study highlights the high frequency and severity of FD in patients with advanced cancer in the U.S. and France as well as its impact on their physical and emotional symptoms and their quality of life in these different health care systems. It is necessary for all health care providers to explore and evaluate the presence of FD in patients living with life-threatening illnesses.</p></div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30877191</PMID><DateCompleted><Year>2020</Year><Month>07</Month><Day>24</Day></DateCompleted><DateRevised><Year>2020</Year><Month>07</Month><Day>24</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1549-490X</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>8</Issue><PubDate><Year>2019</Year><Month>08</Month></PubDate></JournalIssue><Title>The oncologist</Title><ISOAbbreviation>Oncologist</ISOAbbreviation></Journal><ArticleTitle>Inequalities in Financial Distress, Symptoms, and Quality of Life Among Patients with Advanced Cancer in France and the U.S.</ArticleTitle><Pagination><MedlinePgn>1121-1127</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1634/theoncologist.2018-0353</ELocationID><Abstract><AbstractText Label="BACKGROUND">Financial distress (FD) is common among patients with advanced cancer. Our purpose was to compare the frequency and intensity of FD and its associations with symptom distress and quality of life (QOL) in these patients in France and the U.S.</AbstractText><AbstractText Label="MATERIALS AND METHODS">In this secondary analysis of two cross-sectional studies, we assessed data on 292 patients who received cancer care at a public hospital or a comprehensive cancer center in France (143 patients) or the U.S. (149 patients). Outpatients and hospitalized patients over 18 years of age with advanced lung or breast or colorectal or prostate cancer were included. Diagnosed cognitive disorder was considered a noninclusion criterion. Advanced cancer included relapse or metastasis or locally advanced cancer or at least a second-line chemotherapy regimen. Patients self-rated FD and assessed symptoms, psychosocial distress, and QOL on validated questionnaires.</AbstractText><AbstractText Label="RESULTS">The average patient age was 59 years, and 144 (49%) were female. FD and high intensity were reported more frequently in U.S. patients than in French (respectively 129 [88%] vs. 74 [52%], <i>p</i> < .001; 100 [98%] vs. 48 [34%], <i>p</i> < .001,). QOL was rated higher by the U.S. patients than by the French (69 [SD, 18] vs. 63 [SD, 18], <i>p</i> = .003). French patients had more psychological symptoms such as anxiety (8 [SD, 4] vs. 6 [SD, 5], <i>p</i> = .008). Associations were found between FD and U.S. residence, FD and single status (0.907, <i>p</i> = .023), and FD and metastasis (1.538, <i>p</i> = .036). In contrast, negative associations were found between FD and older age (-0.052, <i>p</i> = .003) and FD and France residence (-3.376, <i>p</i> = .001).</AbstractText><AbstractText Label="CONCLUSION">Regardless of health care system, FD is frequent in patients with advanced cancer. U.S. patients were more likely to have FD than French patients but reported better QOL. Further research should focus on factors contributing to FD and opportunities for remediation.</AbstractText><AbstractText Label="IMPLICATIONS FOR PRACTICE">Suffering is experienced in any component of the lives of patients with a life-threatening illness. Financial distress (FD) is one of the least explored cancer-related symptoms, and there are limited studies describing its impact on this frail population. This study highlights the high frequency and severity of FD in patients with advanced cancer in the U.S. and France as well as its impact on their physical and emotional symptoms and their quality of life in these different health care systems. It is necessary for all health care providers to explore and evaluate the presence of FD in patients living with life-threatening illnesses.</AbstractText><CopyrightInformation>© AlphaMed Press 2019.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Barbaret</LastName><ForeName>Cécile</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0001-7144-7115</Identifier><AffiliationInfo><Affiliation>Department of Supportive and Palliative Care, Centre Hospitalo-Universitaire de Grenoble, La Tronche, France cbarbaret@chu-grenoble.fr.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Delgado-Guay</LastName><ForeName>Marvin O</ForeName><Initials>MO</Initials><AffiliationInfo><Affiliation>Department of Palliative, Rehabilitation, and Integrative Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, U.S.A.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sanchez</LastName><ForeName>Stéphane</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Medical Information, Evaluation and Performance, Hôpitaux Champagne Sud, Troyes, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brosse</LastName><ForeName>Christelle</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Palliative Care, Institut de Cancérologie de la Loire, Saint-Etienne, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ruer</LastName><ForeName>Murielle</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Supportive and Palliative Care, Centre Hospitalier Lyon-Sud, Lyon, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rhondali</LastName><ForeName>Wadih</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Supportive and Palliative Care, Centre Hospitalier Lyon-Sud, Lyon, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Monsarrat</LastName><ForeName>Léa</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Supportive and Palliative Care, Centre Hospitalier Lyon-Sud, Lyon, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Michaud</LastName><ForeName>Patrick</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Palliative Care, Institut de Cancérologie de la Loire, Saint-Etienne, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schott</LastName><ForeName>Anne Marie</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Pôle IMER, Hospices Civils de Lyon, Lyon, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bruera</LastName><ForeName>Eduardo</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Palliative, Rehabilitation, and Integrative Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, U.S.A.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Filbet</LastName><ForeName>Marilène</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Supportive and Palliative Care, Centre Hospitalier Lyon-Sud, Lyon, France.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>03</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Oncologist</MedlineTA><NlmUniqueID>9607837</NlmUniqueID><ISSNLinking>1083-7159</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017281" MajorTopicYN="Y">Cost of Illness</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003431" MajorTopicYN="Y">Cross-Cultural Comparison</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005602" MajorTopicYN="N" Type="Geographic">France</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054624" MajorTopicYN="Y">Health Status Disparities</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009367" MajorTopicYN="N">Neoplasm Staging</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009369" MajorTopicYN="N">Neoplasms</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000191" MajorTopicYN="Y">economics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="Y">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057566" MajorTopicYN="N">Self Report</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics & numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012959" MajorTopicYN="N">Socioeconomic Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">Advanced cancer</Keyword><Keyword MajorTopicYN="Y">Financial distress</Keyword><Keyword MajorTopicYN="Y">Palliative care</Keyword><Keyword MajorTopicYN="Y">Quality of life</Keyword><Keyword MajorTopicYN="Y">Symptom distress</Keyword></KeywordList><CoiStatement>Disclosures of potential conflicts of interest may be found at the end of this article.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>06</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>01</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>3</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>7</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>3</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30877191</ArticleId><ArticleId IdType="pii">theoncologist.2018-0353</ArticleId><ArticleId IdType="doi">10.1634/theoncologist.2018-0353</ArticleId><ArticleId IdType="pmc">PMC6693692</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>PLoS One. 2017 May 18;12(5):e0176470</Citation><ArticleIdList><ArticleId IdType="pubmed">28545063</ArticleId></ArticleIdList></Reference><Reference><Citation>Palliat Med. 2008 Mar;22(2):111-22</Citation><ArticleIdList><ArticleId IdType="pubmed">18372376</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Clin Oncol. 1982 Dec;5(6):649-55</Citation><ArticleIdList><ArticleId IdType="pubmed">7165009</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychosomatics. 2008 May-Jun;49(3):218-24</Citation><ArticleIdList><ArticleId IdType="pubmed">18448776</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Med. 2009 Aug;122(8):741-6</Citation><ArticleIdList><ArticleId IdType="pubmed">19501347</ArticleId></ArticleIdList></Reference><Reference><Citation>Acta Psychiatr Scand. 1983 Jun;67(6):361-70</Citation><ArticleIdList><ArticleId IdType="pubmed">6880820</ArticleId></ArticleIdList></Reference><Reference><Citation>Med Care. 2006 Mar;44(3):210-5</Citation><ArticleIdList><ArticleId IdType="pubmed">16501391</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Cancer. 2004 Oct;40(15):2243-52</Citation><ArticleIdList><ArticleId IdType="pubmed">15454249</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychooncology. 2013 Apr;22(4):745-55</Citation><ArticleIdList><ArticleId IdType="pubmed">22411485</ArticleId></ArticleIdList></Reference><Reference><Citation>CA Cancer J Clin. 2018 Mar;68(2):153-165</Citation><ArticleIdList><ArticleId IdType="pubmed">29338071</ArticleId></ArticleIdList></Reference><Reference><Citation>Support Care Cancer. 2018 Jan;26(1):175-180</Citation><ArticleIdList><ArticleId IdType="pubmed">28726065</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychooncology. 2011 Jun;20(6):594-600</Citation><ArticleIdList><ArticleId IdType="pubmed">21305646</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Oncol. 2017 Mar 10;35(8):834-841</Citation><ArticleIdList><ArticleId IdType="pubmed">28029308</ArticleId></ArticleIdList></Reference><Reference><Citation>J Palliat Med. 2018 Aug 1;:</Citation><ArticleIdList><ArticleId IdType="pubmed">30067150</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Oncol. 2012 Apr 20;30(12):1310-5</Citation><ArticleIdList><ArticleId IdType="pubmed">22430269</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Oncol. 2011 Jul 10;29(20):2821-6</Citation><ArticleIdList><ArticleId IdType="pubmed">21632508</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Oncol. 2016 Dec;27(12):2224-2229</Citation><ArticleIdList><ArticleId IdType="pubmed">27789469</ArticleId></ArticleIdList></Reference><Reference><Citation>J Oncol Pract. 2010 Mar;6(2):69-73</Citation><ArticleIdList><ArticleId IdType="pubmed">20592778</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2010 Aug 19;363(8):733-42</Citation><ArticleIdList><ArticleId IdType="pubmed">20818875</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2014 May 17;383(9930):1721-30</Citation><ArticleIdList><ArticleId IdType="pubmed">24559581</ArticleId></ArticleIdList></Reference><Reference><Citation>Qual Life Res. 2005 Jun;14(5):1427-32</Citation><ArticleIdList><ArticleId IdType="pubmed">16047518</ArticleId></ArticleIdList></Reference><Reference><Citation>J Palliat Care. 1991 Summer;7(2):6-9</Citation><ArticleIdList><ArticleId IdType="pubmed">1714502</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Intern Med. 2000 Mar 21;132(6):451-9</Citation><ArticleIdList><ArticleId IdType="pubmed">10733444</ArticleId></ArticleIdList></Reference><Reference><Citation>Oncologist. 2015 Sep;20(9):1092-8</Citation><ArticleIdList><ArticleId IdType="pubmed">26205738</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed><affiliations><list><country><li>France</li><li>États-Unis</li></country><region><li>Auvergne-Rhône-Alpes</li><li>Champagne-Ardenne</li><li>Grand Est</li><li>Rhône-Alpes</li><li>Texas</li></region><settlement><li>Lyon</li><li>Saint-Étienne</li><li>Troyes</li></settlement></list><tree><country name="France"><noRegion><name sortKey="Barbaret, Cecile" sort="Barbaret, Cecile" uniqKey="Barbaret C" first="Cécile" last="Barbaret">Cécile Barbaret</name></noRegion><name sortKey="Brosse, Christelle" sort="Brosse, Christelle" uniqKey="Brosse C" first="Christelle" last="Brosse">Christelle Brosse</name><name sortKey="Filbet, Marilene" sort="Filbet, Marilene" uniqKey="Filbet M" first="Marilène" last="Filbet">Marilène Filbet</name><name sortKey="Michaud, Patrick" sort="Michaud, Patrick" uniqKey="Michaud P" first="Patrick" last="Michaud">Patrick Michaud</name><name sortKey="Monsarrat, Lea" sort="Monsarrat, Lea" uniqKey="Monsarrat L" first="Léa" last="Monsarrat">Léa Monsarrat</name><name sortKey="Rhondali, Wadih" sort="Rhondali, Wadih" uniqKey="Rhondali W" first="Wadih" last="Rhondali">Wadih Rhondali</name><name sortKey="Ruer, Murielle" sort="Ruer, Murielle" uniqKey="Ruer M" first="Murielle" last="Ruer">Murielle Ruer</name><name sortKey="Sanchez, Stephane" sort="Sanchez, Stephane" uniqKey="Sanchez S" first="Stéphane" last="Sanchez">Stéphane Sanchez</name><name sortKey="Schott, Anne Marie" sort="Schott, Anne Marie" uniqKey="Schott A" first="Anne Marie" last="Schott">Anne Marie Schott</name></country><country name="États-Unis"><region name="Texas"><name sortKey="Delgado Guay, Marvin O" sort="Delgado Guay, Marvin O" uniqKey="Delgado Guay M" first="Marvin O" last="Delgado-Guay">Marvin O. Delgado-Guay</name></region><name sortKey="Bruera, Eduardo" sort="Bruera, Eduardo" uniqKey="Bruera E" first="Eduardo" last="Bruera">Eduardo Bruera</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/AutomedicationFrancoV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000533 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000533 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= AutomedicationFrancoV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:30877191
|texte= Inequalities in Financial Distress, Symptoms, and Quality of Life Among Patients with Advanced Cancer in France and the U.S.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:30877191" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a AutomedicationFrancoV1
| This area was generated with Dilib version V0.6.38. |  |